Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lisa Mészáros"'
Publikováno v:
Contemporary Clinical Trials Communications, Vol 38, Iss , Pp 101266- (2024)
Background: The estimands framework represents a significant innovation for the design, conduct, analysis, and interpretation of clinical trials. An aim of the framework is to increase precision and transparency on the handling of intercurrent events
Externí odkaz:
https://doaj.org/article/5d7639251c6f447cbe1647f822544dc9
Autor:
Lisa Mészáros, Markus J. Riemenschneider, Heiko Gassner, Franz Marxreiter, Stephan von Hörsten, Alana Hoffmann, Jürgen Winkler
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-16 (2021)
Abstract Multiple system atrophy (MSA) is a rare, but fatal atypical parkinsonian disorder. The prototypical pathological hallmark are oligodendroglial cytoplasmic inclusions (GCIs) containing alpha-synuclein (α-syn). Currently, two MSA phenotypes a
Externí odkaz:
https://doaj.org/article/f39eb5bd488a45678683fe0a35439f1a
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 2775, p 2775 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Multiple system atrophy (MSA) is a rare, severe, and rapidly progressive neurodegenerative disorder categorized as an atypical parkinsonian syndrome. With a mean life expectancy of 6–9 years after diagnosis, MSA is clinically characterized by parki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d859381c3d32d34a137ef52addcf13f0
https://opus4.kobv.de/opus4-fau/files/20472/ijms-21-02775-v2.pdf
https://opus4.kobv.de/opus4-fau/files/20472/ijms-21-02775-v2.pdf
